<DOC>
	<DOCNO>NCT00242775</DOCNO>
	<brief_summary>The purpose study compare efficacy safety variable dose Symbicort high fix maintenance dose another asthma medication , Seretide , treatment asthma .</brief_summary>
	<brief_title>Comparison Efficacy/Safety Symbicort® Turbuhaler® , Seretide™ Diskus™ 50/500 µg &amp; Terbutaline Turbuhaler® 0.4 mg</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Terbutaline</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Diagnosed asthma since least 6 month prior first visit Prescribed daily use glucocorticosteroids least 3 month prior first visit At least one asthma exacerbation one less twelve month prior first visit Respiratory infection affect asthma within 30 day first visit Use oral , rectal , parenteral glucocorticosteroids within 30 day first visit Any significant disease disorder may jeopardize safety patient Additional inclusion exclusion criterion evaluate Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Asthma</keyword>
</DOC>